Webdisclosure.com

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

17/03/2022 07:00

Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Final Data from Its Clinical Trial of Novel Nasal Spray, Sentinox, in SARS-CoV-2 Infected Patients

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

15/03/2022 07:30

Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research Signs an Agreement To Acquire Rights to Commercialize a Novel Dosage Form for the Treatment of PKU

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

15/03/2022 07:00

Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research Signs an Agreement To Acquire Rights to Commercialize a Novel Dosage Form for the Treatment of PKU

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

16/02/2022 07:25

Relief Reports that its U.S. Collaboration Partner has Announced that the U.S. National Institutes of Health Study of Aviptadil in Critical COVID-19 is Cleared to Complete Full Enrollment

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

16/02/2022 07:00

EQS-Adhoc: Relief Reports that its U.S. Collaboration Partner has Announced that the U.S. National Institutes of Health Study of Aviptadil in Critical COVID-19 is Cleared to Complete Full Enrollment

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

08/02/2022 07:30

Relief Files Trademark Application for RLF-100 With the U.S. Patent and Trademark Office

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

08/02/2022 07:00

EQS-Adhoc: Relief Files Trademark Application for RLF-100 With the U.S. Patent and Trademark Office

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

02/02/2022 07:20

Relief Therapeutics Expands Its Board of Directors with the Appointment of Michelle Lock

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

02/02/2022 07:00

EQS-News: Relief Therapeutics Expands Its Board of Directors with the Appointment of Michelle Lock

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

01/02/2022 07:25

Relief Announces That Collaboration Partner, Acer Therapeutics, was Issued U.S. Patent 11,202,767 Covering ACER-001 Methods of Use for Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease

Voir tous les communiqués de Relief Therapeutics Holdings AG

«
3
4
5
6
7
8
9
10